Euphoria India Pharma

T Nagar, Chennai, Tamil Nadu

GST No. 33AGQPV7819N1ZD

Send Email
Send SMS
Search

Home » Our Product Range » Multi Medicine


Multi Medicine

Leading Wholesale Distributor of sofosbuvir tablet, daclatasvir 60mg, sofosbuvir 400mg tablets and ledipasvir from Chennai.

Sofosbuvir Tablet

REQUEST CALLBACK

Sofosbuvir Tablet
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 8,400 / PieceGet Latest Price

Product Details:
Strength/Dose (in mg or ml)400mg
Pack Size28
Product TypeFinish Product
Brand PreferenceNatco

sofosbuvir is an antiviral medication that prevents hepatitis C virus (HCV) cells from multiplying in your body.

is used in combination with other medications to treat hepatitis C in adults. Sofosbuvir is sometimes used in people who also have HIV, or people who have liver cancer and are going to have a liver transplant. This medicine is not a treatment for HIV or AIDS.

must be given in combination with other antiviral medications and should not be used alone. is usually given with ribavirin with or without peginterferon alfa

is also used together with Daclatasvir to treat hepatitis C genotype 3 infection in adults.

You should not use you are allergic to sofosbuvir.

To make sure is safe for you, tell your doctor if you have:

  • liver problems other than hepatitis, or if you have had a liver transplant;

  • kidney disease (or if you are on dialysis);

  • HIV (human immunodeficiency virus); or

  • if you have recently used a heart rhythm medicine called .

is used in combination with ribavirin. Ribavirin can cause birth defects or death in an unborn baby. You may need to have a negative pregnancy test before using these medications together, and every month during your treatment.

  • If you are a woman, do not use with ribavirin if you are pregnant.

  • If you are a man, do not use this drug combination if your partner is pregnant. An unborn baby could also be harmed if a man fathers the child while he is taking ribavirin.

  • Use at least 2 effective forms of non hormonal birth control (, diaphragm with spermicide) while either partner is using these medications together. Keep using 2 forms of birth control for at least 6 months after treatment ends. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using with ribavirin.

 

It is not known whether sofosbuvir passes into breast milk or if it could harm a nursing baby. You should not breast-feed while using this medicine.

400 mg orally once a day

Recommended Regimens:
-Genotype 1 or 4 chronic hepatitis C (CHC): , peginterferon alfa, and ribavirin
-Genotype 2 CHC: and ribavirin
-Genotype 3 CHC: and ribavirin
-Hepatocellular carcinoma awaiting liver transplantation: and ribavirin

Duration of Therapy:
-Genotype 1 or 4 CHC: 12 weeks
-Genotype 2 CHC: 12 weeks
-Genotype 3 CHC: 24 weeks
-Hepatocellular carcinoma awaiting liver transplantation: Up to 48 weeks or until time of liver transplantation (whichever occurs first)

Comments:
-Sofosbuvir should be used in combination with ribavirin or with pegylated and ribavirin.
-Efficacy was established in patients with HCV genotype 1, 2, 3, or 4 infection, including patients with hepatocellular carcinoma meeting Milan criteria (awaiting liver transplantation) and HCV/HIV-1 coinfected patients.
-and ribavirin therapy for 24 weeks can be considered for patients with genotype 1 CHC who cannot use an -based regimen; treatment decision should be guided by benefits/risks assessment for the individual patient.
-and ribavirin therapy is recommended for patients with hepatocellular carcinoma awaiting liver transplantation to prevent posttransplant HCV reinfection.

Approved indication: As a part of a combination antiviral treatment regimen, for the treatment of chronic hepatitis C infection

Yes! I am Interested

Daclatasvir 60mg

REQUEST CALLBACK

Daclatasvir 60mg
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 3,200 / PieceGet Latest Price

Product Details:
Packaging Size28
Packaging Typebottle
Dose/Strength (ex. 1 mg or 1 ml)60mg
UsageHospital

Daclatasvir is a drug for the treatment of hepatitis C (HCV). It is approved for Hepatitis C genotype 3 infections.

Daclatasvir inhibits the HCV nonstructural protein NS5A. Recent research suggests that it targets two steps of the viral replication process, enabling rapid decline of HCV RNA.

Daclatasvir has been tested in combination regimens with pegylated interferonand ribavirin,as well as with other direct-acting antiviral agents including asunaprevir and sofosbuvir.

Yes! I am Interested

Sofosbuvir 400mg Tablets

REQUEST CALLBACK

Sofosbuvir 400mg Tablets
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 7,200 / PieceGet Latest Price

Product Details:
Strength/Dose (in mg or ml)400
Pack Size28
Product TypeFinish Product
Brand PreferenceNatco

Drug Name:- Sofosbuvir

Strength:- 400mg

Packing:- Pack of 28 Tablet

Uses:- Sofosbuvir 400mg Tablet containing the active ingredient sofosbuvir is a nucleotide polymerase inhibitor type of antiviral medication used to treat Hepatitis C. Sofosbuvir Tablets must be used in combination with other antiviral medicines to reduce the amount of hepatitis C virus (HCV) in the body to help the liver recover. Chronic hepatitis C infections can cause serious liver problems such as liver cancer or cirrhosis (scarring). Patients with HIV or liver cancer and are going to have a liver transplant may also use the drug to decrease the risk of reinfection after the transplant.

Side Effects :- Nausea, Diarrhea, Headaches, Loss of appetite, Lower back or side pain, Insomnia,Fever.

Yes! I am Interested

Sofosbuvir Tablet

REQUEST CALLBACK

Sofosbuvir Tablet
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 7,600 / PieceGet Latest Price

Product Details:
Strength/Dose (in mg or ml)400
Pack Size28
Product TypeFinish Product
Brand PreferenceCipla

sofosbuvir is an antiviral medication that prevents hepatitis C virus (HCV) cells from multiplying in your body.

is used in combination with other medications to treat hepatitis C in adults. Sofosbuvir is sometimes used in people who also have HIV, or people who have liver cancer and are going to have a liver transplant. This medicine is not a treatment for HIV or AIDS.

must be given in combination with other antiviral medications and should not be used alone. is usually given with ribavirin with or without peginterferon alfa

is also used together with Daclatasvir to treat hepatitis C genotype 3 infection in adults.

You should not use you are allergic to sofosbuvir.

To make sure is safe for you, tell your doctor if you have:

  • liver problems other than hepatitis, or if you have had a liver transplant;

  • kidney disease (or if you are on dialysis);

  • HIV (human immunodeficiency virus); or

  • if you have recently used a heart rhythm medicine called .

is used in combination with ribavirin. Ribavirin can cause birth defects or death in an unborn baby. You may need to have a negative pregnancy test before using these medications together, and every month during your treatment.

  • If you are a woman, do not use with ribavirin if you are pregnant.

  • If you are a man, do not use this drug combination if your partner is pregnant. An unborn baby could also be harmed if a man fathers the child while he is taking ribavirin.

  • Use at least 2 effective forms of non hormonal birth control (, diaphragm with spermicide) while either partner is using these medications together. Keep using 2 forms of birth control for at least 6 months after treatment ends. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using with ribavirin.

 

It is not known whether sofosbuvir passes into breast milk or if it could harm a nursing baby. You should not breast-feed while using this medicine.

400 mg orally once a day

Recommended Regimens:
-Genotype 1 or 4 chronic hepatitis C (CHC): , peginterferon alfa, and ribavirin
-Genotype 2 CHC: and ribavirin
-Genotype 3 CHC: and ribavirin
-Hepatocellular carcinoma awaiting liver transplantation: and ribavirin

Duration of Therapy:
-Genotype 1 or 4 CHC: 12 weeks
-Genotype 2 CHC: 12 weeks
-Genotype 3 CHC: 24 weeks
-Hepatocellular carcinoma awaiting liver transplantation: Up to 48 weeks or until time of liver transplantation (whichever occurs first)

Comments:
-Sofosbuvir should be used in combination with ribavirin or with pegylated and ribavirin.
-Efficacy was established in patients with HCV genotype 1, 2, 3, or 4 infection, including patients with hepatocellular carcinoma meeting Milan criteria (awaiting liver transplantation) and HCV/HIV-1 coinfected patients.
-and ribavirin therapy for 24 weeks can be considered for patients with genotype 1 CHC who cannot use an -based regimen; treatment decision should be guided by benefits/risks assessment for the individual patient.
-and ribavirin therapy is recommended for patients with hepatocellular carcinoma awaiting liver transplantation to prevent posttransplant HCV reinfection.

Approved indication: As a part of a combination antiviral treatment regimen, for the treatment of chronic hepatitis C infection

Yes! I am Interested

Daclatasvir 60mg

REQUEST CALLBACK

Daclatasvir 60mg
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 3,200 / PieceGet Latest Price

Product Details:
Packaging Size28
Packaging Typebottle
Dose/Strength (ex. 1 mg or 1 ml)60mg
UsageHospital

Daclatasvir is a drug for the treatment of hepatitis C (HCV). It is approved for Hepatitis C genotype 3 infections.

Daclatasvir inhibits the HCV nonstructural protein NS5A. Recent research suggests that it targets two steps of the viral replication process, enabling rapid decline of HCV RNA.

Daclatasvir has been tested in combination regimens with pegylated interferonand ribavirin,as well as with other direct-acting antiviral agents including asunaprevir and sofosbuvir.

Yes! I am Interested

Ledipasvir

REQUEST CALLBACK

Ledipasvir
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 7,600 / PieceGet Latest Price

Product Details:
Packaging Size28
Packaging TypeBottle
Dose/Strength (ex. 1 mg or 1 ml)400
UsageHospital

Assisted by our seasoned pharmacists, we are offering a distinguished This is well known as an accurate composition of appropriate chemical compounds and natural substances. It should be used under proper medical guidance and advice. The offered tablet is rigorously tested on diverse parameters of quality ensuring its effectiveness. Moreover, the offered tablet is available as per the needs of clients at affordable price.

Features:

  • Anti infectious
  • Anti-bacterial
  • Highly effective

Specifications:

  • Therapy-naive patients without cirrhosis: 12 weeks; 8 weeks can be considered if pretreatment HCV RNA less than 6 million international units/mL
  • Therapy-naive patients with cirrhosis: 12 weeks
  • Therapy-experienced patients without cirrhosis: 12 weeks
  • Therapy-experienced patients with cirrhosis: 24 weeks

Comments:

  • Relapse rates are affected by baseline host and viral factors and differ between durations of therapy for some subgroups.
  • Therapy-experienced patients are those patients who have failed treatment with either peginterferon alfa/ribavirin or peginterferon alfa/ribavirin/HCV protease inhibitor.


Other Information
  • Minimum Order Quantity: 3 bottle
Yes! I am Interested

 
X


Explore More Products

Contact via E-mail
Contact via SMS
Euphoria India Pharma
Viswa (Proprietor)
T-Nagar ,
Chennai - 600017, Tamil Nadu, India
Call Us: 
Call Response Rate: 70%
Share Us :
F G T L



Home  |   About Us   |  Our Product Range  |  Site Map  |   Contact Us

© Euphoria India Pharma. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited

Euphoria India Pharma